Ad
related to: osiis immunization registry new jersey
Search results
Results from the Health.Zone Content Network
On July 12, 2021, Governor Phil Murphy announced that New Jersey residents with a valid email address or phone number on-file with New Jersey Immunization Information System (NJIIS) could access a digital replacement copy of their COVID-19 immunization record using the Docket app in partnership with New York-based Docket Health, Inc.
Immunization registry. An immunization registry or immunization information system ( IIS) is an information system that collects vaccination data about all persons within a geographic area. It consolidates the immunization records from multiple sources for each person living in its jurisdiction.
Medical uses The vaccine is administered intranasally and requires a single dose. Pharmacology COVI-VAC is a live attenuated vaccine. Clinical trials Phase I In December 2020, Codagenix started a Phase I trial in the United Kingdom. In September 2021, Codagenix reported that the trial had shown COVI-VAC to be safe and immunogenic. References ^ "Serum Institute starts manufacturing Codagenix's ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file
For premium support please call: 800-290-4726 more ways to reach us
The trial is designed to rapidly evaluate the efficacy and safety of promising new candidate vaccines selected by an independent vaccine prioritization advisory group. Adolescents trial. In July 2021, Medigen commenced phase II trials for adolescents aged 12–18. Authorization
In April 2020, the company began human Phase I safety studies of its lead vaccine (INO-4800) in the United States, and a Phase I-II trial in South Korea, to test for immunization against the COVID-19 virus.
References ^ "Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults". jrct.niph.go.jp. Japan Registry of Clinical Trials. Retrieved 21 March 2021. ^ "A Phase 2/3 Study of S-268019". jrct.niph.go.jp. Japan Registry of Clinical Trials. Retrieved 20 October 2021. ^ Hashimoto M, Nagata N, Homma T, Maeda H, Dohi K, Seki NM, et al ...
Ad
related to: osiis immunization registry new jersey